Tvardi Therapeutics, Inc. (TVRD) ownership: Top institutional holder: Invesco Ltd. ($3.22M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Invesco Ltd. | 82614.00 | $3.22M | 2025-09-30 |
| Slate Path Capital LP | 704118.00 | $2.24M | 2026-03-31 |
| VANGUARD GROUP INC | 424821.00 | $1.83M | 2025-12-31 |
| BlackRock, Inc. | 388075.00 | $1.23M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 344708.00 | $1.10M | 2026-03-31 |
| AMERICAN FINANCIAL GROUP INC | 223659.00 | $711236.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 182339.00 | $579957.00 | 2026-03-31 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 101034.00 | $321288.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-01-29 | |
| Sell | null | 2026-01-29 | |
| Sell | null | 2026-01-29 |
Back to TVRD overview · TVRD earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.